HIV -1
Showing 9951 - 9975 of >10,000
Parkinson Disease, Alzheimer Trial in Vitória (Probiotic K10, Placebo)
Active, not recruiting
- Parkinson Disease
- Alzheimer Disease
- Probiotic K10
- Placebo
-
Vitória, ES, BrazilGon1 gestora de Projetos
Aug 24, 2023
Total Knee Replacement Trial (Mepivacaine Spinal, Bupivacaine Spinal)
Not yet recruiting
- Total Knee Replacement
- Mepivacaine Spinal
- Bupivacaine Spinal
- (no location specified)
Mar 9, 2023
HIV Trial in Entebee (HealthScouts, Standard of Care)
Completed
- HIV
- HealthScouts
- Standard of Care
-
Entebee, UgandaRakai Health Sciences Program
Aug 28, 2020
Type 1 Diabetes Mellitus and Increased Weight on Gut Microbiome
Completed
- Obesity
- +2 more
- No intervention
-
San Diego, CaliforniaRady Children's Hospital Endocrinology Department
May 26, 2022
The Use of Wireless Sensors in Neonatal Intensive Care
Not yet recruiting
- Preterm Birth
- Apnea of Newborn
- ANNE™ Monitoring System (2 sensors)
- ANNE™ Monitoring System (3 sensors)
-
Montréal, Quebec, CanadaMontreal Children's Hospital
Jul 12, 2022
Endometrial Cancer Stage I, Sentinel Lymph Node, Surgery Trial in Australia, Singapore (TH BSO with SNB Note: If participants
Recruiting
- Endometrial Cancer Stage I
- +2 more
- TH BSO with SNB Note: If participants (≤45 years of age) wish to retain their ovaries a BSO may be omitted.
- TH BSO without retroperitoneal node dissection Note: If participants (≤45 years of age) wish to retain their ovaries a BSO may be omitted.
-
Camperdown, New South Wales, Australia
- +12 more
Sep 7, 2022
Glioblastoma Multiforme of Brain Trial run by the (Ketogenic Diet, Standardized Diet)
Completed
- Glioblastoma Multiforme of Brain
- Ketogenic Diet
- Standardized Diet
-
Bethesda, MarylandMidAtlantic Epilepsy and Sleep Center
Aug 10, 2022
Melanoma (Skin) Trial in Tampa (MART-1, NY-ESO-1, gp100:209-217(210M))
Completed
- Melanoma (Skin)
- MART-1
- +5 more
-
Tampa, FloridaH. Lee Moffitt Cancer Center and Research Institute
Jan 17, 2023
Subclinical Transthyretin Cardiac Amyloidosis in V122I TTR
Not yet recruiting
- Amyloidosis, Hereditary
- +4 more
-
New York, New York
- +2 more
Aug 3, 2022
Diet Habit, Obesity Trial in Knoxville (Order 1, Order 2, Order 3)
Recruiting
- Diet Habit
- Obesity
- Order 1
- +3 more
-
Knoxville, TennesseeUniversity of Tennessee, Knoxville
Aug 2, 2022
Solid Tumor Trial in Italy, United States (Derazantinib low dose range, Derazantinib middle dose range, Derazantinib high dose
Completed
- Solid Tumor
- Derazantinib low dose range
- +3 more
-
Scottsdale, Arizona
- +11 more
Mar 7, 2022
Gastric Cancer, Pancreatic Cancer, Advanced Ovarian Carcinoma Trial (Claudin 18.2 CAR-T)
Not yet recruiting
- Gastric Cancer
- +3 more
- Claudin 18.2 CAR-T
- (no location specified)
Jul 21, 2022
Tumor Metastasis Trial in Canada, United Kingdom, United States (BI 754091, BI 754111, BI 836880)
Active, not recruiting
- Neoplasm Metastasis
- BI 754091
- +2 more
-
La Jolla, California
- +16 more
Jan 9, 2023
Alzheimer, Mild Cognitive Impairment Trial in Los Angeles (Brivaracetam)
Not yet recruiting
- Alzheimer Disease
- Mild Cognitive Impairment
-
Los Angeles, CaliforniaMary S. Easton Center for Alzheimer's Research and Care
Jun 1, 2023
Cystic Fibrosis Trial in Worldwide (VX-121/TEZ/D-IVA, ELX/TEZ/IVA, IVA)
Active, not recruiting
- Cystic Fibrosis
- VX-121/TEZ/D-IVA
- +5 more
-
Birmingham, Alabama
- +169 more
Dec 22, 2022
Breast Tumor Trial in México (Hybrid lifestyle educational multidisciplinary intervention., Hybrid lifestyle personalized
Recruiting
- Breast Neoplasm
- Hybrid lifestyle educational multidisciplinary intervention.
- Hybrid lifestyle personalized multidisciplinary intervention.
-
México, MexicoDr. Marlid Cruz Ramos
Oct 13, 2023
Maturity-onset Diabetes of the Young, Monogenic Diabetes, MODY Trial (Genetic testing for 4 MODY genes (GCK, HNF1A, HNF4A,
Not yet recruiting
- Maturity-onset Diabetes of the Young
- +2 more
- Genetic testing for 4 MODY genes (GCK, HNF1A, HNF4A, HNF1B)
- (no location specified)
Oct 19, 2022
IgA Nephropathy (IgAN), Berger Disease, Glomerulonephritis, IgA Trial in Worldwide (Placebo, Cemdisiran)
Active, not recruiting
- IgA Nephropathy (IgAN)
- +2 more
- Placebo
- Cemdisiran
-
Vancouver, British Columbia, Canada
- +19 more
Jan 13, 2023
Sensorineural Hearing Loss Trial (Blood sampling, Perilymph sampling)
Not yet recruiting
- Sensorineural Hearing Loss
- Blood sampling
- Perilymph sampling
- (no location specified)
Jan 2, 2023
SARS-CoV-2 Specific CD8 T-Cell Responses to COVID-19 Vaccines in
Recruiting
- COVID-19
-
Baltimore, Maryland
- +1 more
Feb 2, 2023
Malaria Trial in Ou(SqrRoot)(Copyright)less(SqrRoot)(Copyright)bougou (biological, other, drug)
Suspended
- Malaria
- PfSPZ Vaccine
- +2 more
-
Ou(SqrRoot)(Copyright)less(SqrRoot)(Copyright)bougou, MaliOu(SqrRoot)(Copyright)less(SqrRoot)(Copyright)bougou, Health Res
Feb 2, 2023
Hepatocellular Carcinoma, Hepatocellular Cancer, Metastatic Pancreatic Cancer Trial run by the NCI (nivolumab, tadalafil, oral
Completed
- Hepatocellular Carcinoma
- +4 more
- nivolumab
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Feb 2, 2023
Stroke, Stroke, Acute, Stroke, Subacute Trial in Belgium, France, Luxembourg (Use of the Atalante exoskeleton)
Completed
- Stroke
- +3 more
- Use of the Atalante exoskeleton
-
Bruxelles, Belgium
- +5 more
Apr 26, 2022
Hepatitis B Trial in Cambridge (GSK3965193, Placebo to match GSK3965193, Bepirovirsen)
Recruiting
- Hepatitis B
- GSK3965193
- +2 more
-
Cambridge, United KingdomGSK Investigational Site
Jun 14, 2022